There is considerable evidence suggesting that a high expression of CD44 is associated with tumor progression and recurrence [31, 32], which is similar to the other two variant isoforms that have also been reported to be involved in cancer progression and recurrence [33–35]. The gene discussed is CD44; the disease is cancer.